https://www.healio.com/news/rheumatology/20230109/patients-with-imids-hybrid-immunity-may-be-able-to-delay-fourth-covid19-vaccine-dose
Patients with immune-mediated inflammatory disease undergoing immunosuppressive therapy gain a “significant immunological boost” following SARS-CoV-2 infection, according to data published in The Lancet Rheumatology.The researchers added that pati…
Create an account
or login to join the discussion